Results 31 to 40 of about 139,649 (304)

Subcutaneous palivizumab (Synagis®) administration in an infant with congenital type 2B von Willebrand disease

open access: yesJournal of Pediatric and Neonatal Individualized Medicine, 2015
Intramuscular injections are contra-indicated in infants with either acquired or congenital bleeding disorders. In such patients, it is unlicensed practice to administer vaccines by subcutaneous route.
Karel Allegaert   +3 more
doaj   +1 more source

The Evaluation of Local and Systemic Reactions to Subcutaneous House Dust Mite Allergen Immunotherapy

open access: yesTrends in Pediatrics, 2022
Objective: Allergen-specific immunotherapy is an effective treatment method that enables the development of immunotolerance against allergens in allergic rhinitis, asthma, and venom allergy.
Zuhal Karalı   +4 more
doaj   +1 more source

Patients’ independence of a nurse for the administration of subcutaneous anti-TNF therapy: A phenomenographic study

open access: yesInternational Journal of Qualitative Studies on Health & Well-Being, 2010
Rheumatology nursing supports patients to manage their lives and live as independently as possible without pain, stiffness and functional restrictions.
Ingrid Larsson   +3 more
doaj   +1 more source

Basic Practical Skills: Subcutaneous, Intramuscular and Intradermal Injections in Adults [PDF]

open access: yes, 2023
Basic practical skills: subcutaneous, intramuscular, and intradermal injection techniques in adults Learn the anatomy relevant to subcutaneous (SC), intramuscular (IM), and intradermal (ID) injection techniques, and the procedure for each injection ...
Ogston-Tuck, Sherri   +1 more
core  

Deep subcutaneous application of poly-L-lactic acid as a filler for facial lipoatrophy in HIV-infected patients [PDF]

open access: yes, 2005
Introduction: Facial lipoatrophy is a crucial problem of HIV-infected patients undergoing highly active antiretroviral therapy (HAART). Poly-L-lactic acid (PLA), provided as New-Fill(R)/Sculptra(TM), is known as one possible treatment option. In 2004 PLA
Borelli, Claudia   +5 more
core   +1 more source

Preference for Subcutaneous Injection or Intravenous Infusion of Biological Therapy Among Italian Patients With SLE

open access: yesJournal of Patient Experience, 2019
This article focuses on the patients’ acceptance of a subcutaneous injection device for patients with systemic lupus erythematosus, which in the upcoming years could be introduced beside the intravenous infusion of biological therapy.
Marina Falanga MSc   +2 more
doaj   +1 more source

Cytosine arabinoside constant rate infusion without subsequent subcutaneous injections for the treatment of dogs with meningoencephalomyelitis of unknown origin [PDF]

open access: yes, 2020
Background: The administration of cytosine arabinoside (CA) by continuous rate infusion (CRI) at the time of diagnosis has been shown to improve the 3-month survival of dogs diagnosed with meningoencephalomyelitis of unknown origin (MUO), compared to ...
Broeckx, Bart   +10 more
core   +2 more sources

Model study of the pressure build-up during subcutaneous injection. [PDF]

open access: yesPLoS ONE, 2014
In this study we estimate the subcutaneous tissue counter pressure during drug infusion from a series of injections of insulin in type 2 diabetic patients using a non-invasive method. We construct a model for the pressure evolution in subcutaneous tissue
Maria Thomsen   +6 more
doaj   +1 more source

Organ‐specific redox imbalances in spinal muscular atrophy mice are partially rescued by SMN antisense oligonucleotides

open access: yesFEBS Letters, EarlyView.
We identified a systemic, progressive loss of protein S‐glutathionylation—detected by nonreducing western blotting—alongside dysregulation of glutathione‐cycle enzymes in both neuronal and peripheral tissues of Taiwanese SMA mice. These alterations were partially rescued by SMN antisense oligonucleotide therapy, revealing persistent redox imbalance as ...
Sofia Vrettou, Brunhilde Wirth
wiley   +1 more source

Large cutaneous-subcutaneous infiltrates: a side effect of interferon beta injections [PDF]

open access: yes, 1998
Interferon alpha and gamma have been used to treat several hepatic, hematological and oncological diseases for years. Recently, interferon beta has been introduced as a therapeutic agent in relapsing-remitting multiple sclerosis.
Soyer, P   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy